Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Andrew David Luster, M.D., Ph.D.

Co-Author

This page shows the publications co-authored by Andrew Luster and Bruce Walker.
Connection Strength

0.671
  1. Decreased CXCR3+ CD8 T cells in advanced human immunodeficiency virus infection suggest that a homing defect contributes to cytotoxic T-lymphocyte dysfunction. J Virol. 2007 Aug; 81(16):8439-50.
    View in: PubMed
    Score: 0.092
  2. IL-8 responsiveness defines a subset of CD8 T cells poised to kill. Blood. 2004 Dec 01; 104(12):3463-71.
    View in: PubMed
    Score: 0.075
  3. HIV-1 specific CD8+ T cells with an effector phenotype and control of viral replication. Lancet. 2004 Mar 13; 363(9412):863-6.
    View in: PubMed
    Score: 0.073
  4. HIV-1 antiviral activity of recombinant natural killer cell enhancing factors, NKEF-A and NKEF-B, members of the peroxiredoxin family. J Biol Chem. 2003 Jan 17; 278(3):1569-74.
    View in: PubMed
    Score: 0.067
  5. Purification of a modified form of bovine antithrombin III as an HIV-1 CD8+ T-cell antiviral factor. J Biol Chem. 2002 Nov 01; 277(44):42352-7.
    View in: PubMed
    Score: 0.066
  6. Monocyte chemoattractant protein-2 (CC chemokine ligand 8) inhibits replication of human immunodeficiency virus type 1 via CC chemokine receptor 5. J Infect Dis. 2002 Apr 15; 185(8):1174-8.
    View in: PubMed
    Score: 0.064
  7. Noncytolytic inhibition of X4 virus by bulk CD8(+) cells from human immunodeficiency virus type 1 (HIV-1)-infected persons and HIV-1-specific cytotoxic T lymphocytes is not mediated by beta-chemokines. J Virol. 2001 Sep; 75(17):8306-16.
    View in: PubMed
    Score: 0.061
  8. Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Nature. 1998 Feb 26; 391(6670):908-11.
    View in: PubMed
    Score: 0.048
  9. Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms. J Virol. 1997 Apr; 71(4):3120-8.
    View in: PubMed
    Score: 0.045
  10. IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infection. Nat Commun. 2015 Jun 25; 6:7562.
    View in: PubMed
    Score: 0.040
  11. Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice. J Virol. 2009 Jul; 83(14):7305-21.
    View in: PubMed
    Score: 0.026
  12. Enhanced inhibition of human immunodeficiency virus type 1 by Met-stromal-derived factor 1beta correlates with down-modulation of CXCR4. J Virol. 1999 Jun; 73(6):4582-9.
    View in: PubMed
    Score: 0.013
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.